BEGIN:VCALENDAR
PRODID:-//Microsoft Corporation//OutlookMIMEDIR//EN
VERSION:2.0
X-WR-TIMEZONE:America/New_York
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:America/New_York
LAST-MODIFIED:20260721T092906Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York;VALUE=DATE:20261015
DTEND;TZID=America/New_York;VALUE=DATE:20261016
DTSTAMP:20260804T124853Z
UID:{5724CCC6-D22E-469A-922BAB431D70CC19}
LOCATION:virtual zoom meeting
SUMMARY:Webinar: Current Progress in Vaccine Development Against Klebsiella pneumoniae From Antigen Discovery to Clinical Translation
DESCRIPTION:<p><i>Klebsiella pneumoniae</i> poses a growing global threat due to rising multidrug resistance and hypervirulence. This talk reviews current vaccine approaches—including glycoconjugates, protein antigens, and OMVs—alongside key translation challenges like antigenic diversity and preclinical models.</p><p><a href="https://www.bocsci.com/current-progress-in-vaccine-development-against-klebsiella-pneumoniae-from-antigen-discovery-to-clinical-translation.html">Event details and registration</a> here.</p>
PRIORITY:1
END:VEVENT
END:VCALENDAR